Towards causal validation and clinical translation of the PAK2–fibroblast axis in idiopathic pulmonary fibrosis
European Respiratory Journal · 2026-03 · 67 (3) · 2502148
DOI: 10.1183/13993003.02148-2025 ↗Kurz gefasst
Leserbrief in der Zeitschrift European Respiratory Journal, online erschienen am 19.03.2026. Verfasst von Man Sun und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, The Second Hospital of Dalian Medical University, Dalian City, China. Die Arbeit nennt 7 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Oncology, The Second Hospital of Dalian Medical University, Dalian City, China.
- These authors contributed equally to this work.
- Department of Oncology, The Second Hospital of Dalian Medical University, Dalian City, China chenjun_dmu@126.com.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Sun, M., Zang, D., & Chen, J. (2026). Towards causal validation and clinical translation of the PAK2–fibroblast axis in idiopathic pulmonary fibrosis. European Respiratory Journal, 67(3), 2502148. https://doi.org/10.1183/13993003.02148-2025
Vancouver
Sun M, Zang D, Chen J. Towards causal validation and clinical translation of the PAK2–fibroblast axis in idiopathic pulmonary fibrosis. European Respiratory Journal. 2026;67(3):2502148. doi:10.1183/13993003.02148-2025
BibTeX
@article{Sun2026,
author = {Sun, Man and Zang, Dan and Chen, Jun},
title = {Towards causal validation and clinical translation of the PAK2–fibroblast axis in idiopathic pulmonary fibrosis},
journal = {European Respiratory Journal},
year = {2026},
volume = {67},
number = {3},
pages = {2502148},
doi = {10.1183/13993003.02148-2025}
}
EUVIMED